Feasibility and safety of PD-1/L1 inhibitors for non-small cell lung cancer in front-line treatment: a Bayesian network meta-analysis.
Liang H, Lin G, Wang W, Huang J, Yang Y, Lan Y, Wang R, Cui F, Hao Z, Deng H, Zhao S, Cheng B, Xiong S, Li J, Li C, Liu J, He J, Liang W.
Liang H, et al. Among authors: zhao s.
Transl Lung Cancer Res. 2020 Apr;9(2):188-203. doi: 10.21037/tlcr.2020.02.14.
Transl Lung Cancer Res. 2020.
PMID: 32420059
Free PMC article.